Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
J Korean Med Sci
; 38(13): e99, 2023 Apr 03.
Article
em En
| MEDLINE
| ID: mdl-37012686
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus
/
Dislipidemias
/
COVID-19
/
Hipertensão
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article